Taysha Gene Therapies
TSHA
$2.57
Share price
-0.39%
Change (1 day)
261.97%
Change (1 year)
Taysha Gene Therapies (TSHA) - P/B ratio
P/B ratio as of May 2024 : 6.44
According to Taysha Gene Therapies's latest financial reports the company has a price-to-book ratio of 6.44.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Taysha Gene Therapies - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.42 | -97.03% |
| 2022-12-31 | 149 | 3064.46% |
| 2021-12-31 | 4.70 | 17.83% |
| 2020-12-31 | 3.99 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -55.51% | 🇺🇸 USA |